allergic to tirzepatide Reactions Tirzepatide: Symptoms and Management Tirzepatide-Induced Injection Site Reaction |

Approximately 2.7% of individuals taking the 0.5 mg dose and 1.1% taking the 1 mg dose report experiencing this side effect during clinical trials

All PlexusDx compounding partners maintain strict quality controls, sterility assurance, and potency verification

A similar risk was observed in boys (adjusted HR: 1.33, 95% CI: 1.201.48

Telehealth screening has limits

The reporting followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines

Flushing and Vascular Stress Both peptides can cause flushing and changes in circulation, creating discomfort or placing added stress on the vascular system